Bryan Health Signs Medline as Primary Medical Supplies Distributor

Nebraska-based healthcare system and Medline partner to enhance supply chain strategy and outcomes

Medline today announced it has entered into a multi-year prime vendor partnership, valued at $140M, with Nebraska-based Bryan Health. After being with a different distributor for over 30 years, the two organizations will collaborate to identify new strategies for enhancing patient outcomes and streamlining supply chain operations for the healthcare system. As the system’s primary supplier, Medline will exclusively provide an extensive portfolio of essential medical supplies and solutions to Bryan’s acute care medical centers in Lincoln, Grand Island, Crete and Central City, in addition to Kearney Regional Medical Center, which is already served by Medline.

“Medline’s proactive approach facilitated a smooth implementation and the customer support has been incredibly responsive,” said Heather Seeba, director of supply chain for Bryan Health. “We look forward to partnering with the Medline experts to optimize our operational processes and improve our supply consistency.”

As part of the agreement, dedicated Medline resources will work with Bryan Health to help address specific caregiver needs and operational efficiencies to support the system’s efforts in providing the highest quality of care for those they serve throughout the region. Bryan Health will also have the ability to easily monitor key metrics such as item utilization, contract compliance, price accuracy and spending by product categories through advanced analytics platforms from Medline.

“Medline is committed to providing Bryan Health with continuously reliable, superior service,” said Megan Schwellenbach, vice president of corporate accounts at Medline. “We are excited to enter into this prime vendor partnership and together develop solutions to help provide consistency and stability to its supply chain.”

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.